Richard Markus, Chief Medical Officer at Arcus Biosciences, Inc. (RCUS), sold 19,092 shares at $22.16 ($420K) on 2025-12-17, disclosed to the SEC on 2025-12-18.
Scheduled sale ($420k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.88 | 5,052 | $111K | 26.3% |
| 2 | $21.88 | 5,052 | $111K | 26.3% |
| 3 | $22.16 | 4,494 | $100K | 23.7% |
| 4 | $22.16 | 4,494 | $100K | 23.7% |
| Total | $22.01 avg | 19,092 | $420K | 100% |